Apple on Thursday said some of its top smartwatch models are getting a redesigned blood oxygen sensing feature, sidelined for several years by a patent dispute. Masimo, based in southern California, filed a complaint to the US International Trade Commission (ITC) which decided to halt imports of the Apple Watch models over a patented technology for detecting blood-oxygen levels.